Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Thrombocythemia, Essential × lestaurtinib × Clear all

Phase

Status

Unknown 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Thrombocythemia, Essential 1 Primary Myelofibrosis 1 Polycythemia Vera 1

Interventions

lestaurtinib 1 fludarabine phosphate 1 Vorinostat 1 Tacrolimus 1 Pharmacogenomic Testing 1 Peripheral Blood Stem Cell Transplantation 1 Mycophenolic Acid 1 Methotrexate 1 Ketamine 1 Histone Deacetylase Inhibitors 1 Filgrastim 1 Cyclophosphamide 1 Busulfan 1 Antilymphocyte Serum 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00668421 2014-11-26

CEP-701 (Lestaurtinib) in Myelofibrosis

Icahn School of Medicine at Mount Sinai

Phase 1/2 Unknown

Polycythemia Vera, Thrombocythemia, Essential, Primary Myelofibrosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡